Global Enoxaparin Sodium Prefilled Syringes Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031
Description
According to our (Global Info Research) latest study, the global Enoxaparin Sodium Prefilled Syringes market size was valued at US$ million in 2024 and is forecast to a readjusted size of USD million by 2031 with a CAGR of %during review period.
Enoxaparin sodium is an anticoagulant medication (blood thinner).It is used to treat and prevent deep vein thrombosis (DVT) and pulmonary embolism (PE) including during pregnancy and following certain types of surgery. It is also used in those with acute coronary syndrome (ACS) and heart attacks. It is given by injection just under the skin or into a vein. Prefilled syringes and graduated prefilled syringes are preservative-free and intended for use only as a single-dose injection.
With the continuous advancement of medical technology, prefilled syringes have been playing an increasingly vital role in the field of pharmaceutical delivery. Enoxaparin sodium, a commonly used anticoagulant medication, is now being offered in the form of prefilled syringes known as Enoxaparin Sodium Prefilled Syringes. This innovative delivery method is gradually becoming the preferred choice for anticoagulant therapy, driven by its convenience and precise dosing capabilities. The Enoxaparin Sodium Prefilled Syringes not only reduce the complexity for healthcare providers but also offer patients a more comfortable and convenient medication experience. As the aging population grows and anticoagulant treatments continue to see widespread adoption, the market for Enoxaparin Sodium Prefilled Syringes is poised for sustained growth.
This report is a detailed and comprehensive analysis for global Enoxaparin Sodium Prefilled Syringes market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Enoxaparin Sodium Prefilled Syringes market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Enoxaparin Sodium Prefilled Syringes market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Enoxaparin Sodium Prefilled Syringes market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Enoxaparin Sodium Prefilled Syringes market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Enoxaparin Sodium Prefilled Syringes
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Enoxaparin Sodium Prefilled Syringes market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Sanofi, Teva, Rovi, Amphastar, Techdow (Hepalink), Fresenius Kabi, Nanjing King-friend, Sandoz, Apotex, Hangzhou Jiuyuan Gene Engineering, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Enoxaparin Sodium Prefilled Syringes market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
20 mg/0.2mL
30 mg/0.3mL
40 mg/0.4mL
60 mg/0.6mL
80 mg/0.8mL
100 mg/1mL
120 mg/0.8mL
150 mg/1mL
Market segment by Application
Hospital
Clinic
Others
Major players covered
Sanofi
Teva
Rovi
Amphastar
Techdow (Hepalink)
Fresenius Kabi
Nanjing King-friend
Sandoz
Apotex
Hangzhou Jiuyuan Gene Engineering
Cipla
Taj Pharma
Chengdu Baiyu Pharmaceutical
Changzhou Qianhong Bio-pharma
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Enoxaparin Sodium Prefilled Syringes product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Enoxaparin Sodium Prefilled Syringes, with price, sales quantity, revenue, and global market share of Enoxaparin Sodium Prefilled Syringes from 2020 to 2025.
Chapter 3, the Enoxaparin Sodium Prefilled Syringes competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Enoxaparin Sodium Prefilled Syringes breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Enoxaparin Sodium Prefilled Syringes market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Enoxaparin Sodium Prefilled Syringes.
Chapter 14 and 15, to describe Enoxaparin Sodium Prefilled Syringes sales channel, distributors, customers, research findings and conclusion.
Enoxaparin sodium is an anticoagulant medication (blood thinner).It is used to treat and prevent deep vein thrombosis (DVT) and pulmonary embolism (PE) including during pregnancy and following certain types of surgery. It is also used in those with acute coronary syndrome (ACS) and heart attacks. It is given by injection just under the skin or into a vein. Prefilled syringes and graduated prefilled syringes are preservative-free and intended for use only as a single-dose injection.
With the continuous advancement of medical technology, prefilled syringes have been playing an increasingly vital role in the field of pharmaceutical delivery. Enoxaparin sodium, a commonly used anticoagulant medication, is now being offered in the form of prefilled syringes known as Enoxaparin Sodium Prefilled Syringes. This innovative delivery method is gradually becoming the preferred choice for anticoagulant therapy, driven by its convenience and precise dosing capabilities. The Enoxaparin Sodium Prefilled Syringes not only reduce the complexity for healthcare providers but also offer patients a more comfortable and convenient medication experience. As the aging population grows and anticoagulant treatments continue to see widespread adoption, the market for Enoxaparin Sodium Prefilled Syringes is poised for sustained growth.
This report is a detailed and comprehensive analysis for global Enoxaparin Sodium Prefilled Syringes market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Enoxaparin Sodium Prefilled Syringes market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Enoxaparin Sodium Prefilled Syringes market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Enoxaparin Sodium Prefilled Syringes market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Enoxaparin Sodium Prefilled Syringes market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Enoxaparin Sodium Prefilled Syringes
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Enoxaparin Sodium Prefilled Syringes market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Sanofi, Teva, Rovi, Amphastar, Techdow (Hepalink), Fresenius Kabi, Nanjing King-friend, Sandoz, Apotex, Hangzhou Jiuyuan Gene Engineering, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Enoxaparin Sodium Prefilled Syringes market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
20 mg/0.2mL
30 mg/0.3mL
40 mg/0.4mL
60 mg/0.6mL
80 mg/0.8mL
100 mg/1mL
120 mg/0.8mL
150 mg/1mL
Market segment by Application
Hospital
Clinic
Others
Major players covered
Sanofi
Teva
Rovi
Amphastar
Techdow (Hepalink)
Fresenius Kabi
Nanjing King-friend
Sandoz
Apotex
Hangzhou Jiuyuan Gene Engineering
Cipla
Taj Pharma
Chengdu Baiyu Pharmaceutical
Changzhou Qianhong Bio-pharma
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Enoxaparin Sodium Prefilled Syringes product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Enoxaparin Sodium Prefilled Syringes, with price, sales quantity, revenue, and global market share of Enoxaparin Sodium Prefilled Syringes from 2020 to 2025.
Chapter 3, the Enoxaparin Sodium Prefilled Syringes competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Enoxaparin Sodium Prefilled Syringes breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Enoxaparin Sodium Prefilled Syringes market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Enoxaparin Sodium Prefilled Syringes.
Chapter 14 and 15, to describe Enoxaparin Sodium Prefilled Syringes sales channel, distributors, customers, research findings and conclusion.
Table of Contents
117 Pages
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
